Anti-COX10 monoclonal antibody
Pre-made anti-COX10 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research
Go to COX10/COX10 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-IP0593-Ab-1/ GM-Tg-hg-IP0593-Ab-2 | Anti-Human COX10 monoclonal antibody | Human |
GM-Tg-rg-IP0593-Ab-1/ GM-Tg-rg-IP0593-Ab-2 | Anti-Rat COX10 monoclonal antibody | Rat |
GM-Tg-mg-IP0593-Ab-1/ GM-Tg-mg-IP0593-Ab-2 | Anti-Mouse COX10 monoclonal antibody | Mouse |
GM-Tg-cynog-IP0593-Ab-1/ GM-Tg-cynog-IP0593-Ab-2 | Anti-Cynomolgus/ Rhesus macaque COX10 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-IP0593-Ab-1/ GM-Tg-felg-IP0593-Ab-2 | Anti-Feline COX10 monoclonal antibody | Feline |
GM-Tg-cang-IP0593-Ab-1/ GM-Tg-cang-IP0593-Ab-2 | Anti-Canine COX10 monoclonal antibody | Canine |
GM-Tg-bovg-IP0593-Ab-1/ GM-Tg-bovg-IP0593-Ab-2 | Anti-Bovine COX10 monoclonal antibody | Bovine |
GM-Tg-equg-IP0593-Ab-1/ GM-Tg-equg-IP0593-Ab-2 | Anti-Equine COX10 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-IP0593-Ab-1/ GM-Tg-hg-IP0593-Ab-2; GM-Tg-rg-IP0593-Ab-1/ GM-Tg-rg-IP0593-Ab-2; GM-Tg-mg-IP0593-Ab-1/ GM-Tg-mg-IP0593-Ab-2; GM-Tg-cynog-IP0593-Ab-1/ GM-Tg-cynog-IP0593-Ab-2; GM-Tg-felg-IP0593-Ab-1/ GM-Tg-felg-IP0593-Ab-2; GM-Tg-cang-IP0593-Ab-1/ GM-Tg-cang-IP0593-Ab-2; GM-Tg-bovg-IP0593-Ab-1/ GM-Tg-bovg-IP0593-Ab-2; GM-Tg-equg-IP0593-Ab-1/ GM-Tg-equg-IP0593-Ab-2 |
Products Name | Anti-COX10 monoclonal antibody |
Format | mab |
Target Name | COX10 |
Protein Sub-location | Introcelluar Protein |
Category of antibody | |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected. |
Tag | Fc |
Products description | Pre-made anti-COX10 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-IP0593-Ag-1 | Recombinant multi-species COX10 protein |
ORF Viral Vector | pGMLP003898 | human COX10 Lentivirus plasmid |
ORF Viral Vector | vGMLP003898 | human COX10 Lentivirus particle |
ORF Viral Vector | pGMLPm002192 | mouse Cox10 Lentivirus plasmid |
ORF Viral Vector | vGMLPm002192 | mouse Cox10 Lentivirus particle |
Target information
Target ID | GM-IP0593 |
Target Name | COX10 |
Gene ID | 1352,70383,691853,718301,489515,101091737,511440,100073118 |
Gene Symbol and Synonyms | 2410004F01Rik,COX10,MC4DN3 |
Uniprot Accession | Q12887 |
Uniprot Entry Name | COX10_HUMAN |
Protein Sub-location | Introcelluar Protein |
Category | |
Disease | N/A |
Gene Ensembl | ENSG00000006695 |
Target Classification | N/A |
The target: COX10, gene name: COX10, also named as . Cytochrome c oxidase (COX), the terminal component of the mitochondrial respiratory chain, catalyzes the electron transfer from reduced cytochrome c to oxygen. This component is a heteromeric complex consisting of 3 catalytic subunits encoded by mitochondrial genes and multiple structural subunits encoded by nuclear genes. The mitochondrially-encoded subunits function in electron transfer, and the nuclear-encoded subunits may function in the regulation and assembly of the complex. This nuclear gene encodes heme A:farnesyltransferase, which is not a structural subunit but required for the expression of functional COX and functions in the maturation of the heme A prosthetic group of COX. This protein is predicted to contain 7-9 transmembrane domains localized in the mitochondrial inner membrane. A gene mutation, which results in the substitution of a lysine for an asparagine (N204K), is identified to be responsible for cytochrome c oxidase deficiency. In addition, this gene is disrupted in patients with CMT1A (Charcot-Marie-Tooth type 1A) duplication and with HNPP (hereditary neuropathy with liability to pressure palsies) deletion. [provided by RefSeq, Jul 2008].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.